Stock listing

PULM Stock Price, News, Filings & Events — Pulmatrix, Inc.

Selected listing: PULM · NASDAQ · USD · US

This page tracks Pulmatrix, Inc.'s PULM:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PULM:NASDAQ. PULM:NASDAQ is the stock-level entry point for investors researching Pulmatrix, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pulmatrix, Inc. is a public company traded under the ticker PULM in the American market. The company has a market capitalization of approximately $6.03 million. Pulmatrix focuses on developing innovative therapies for respiratory diseases.

PULM:NASDAQUSDUSUpdated August 14, 2026
Pulmatrix, Inc. logo
Ticker
PULM:NASDAQ
Asset type
Stock
Market cap
$5.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Pulmatrix, Inc. PULM:NASDAQ stock context

This page tracks Pulmatrix, Inc.'s PULM:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PULM:NASDAQ. PULM:NASDAQ is the stock-level entry point for investors researching Pulmatrix, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pulmatrix, Inc. is a public company traded under the ticker PULM in the American market. The company has a market capitalization of approximately $6.03 million. Pulmatrix focuses on developing innovative therapies for respiratory diseases.

Research Pulmatrix, Inc.

Alternate listings